The global market for Potassium Iodide Tablet is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Potassium Iodide Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Potassium Iodide Tablet players cover Anbex, Inc, Recipharm, BTG Specialty Pharmaceuticals, NOW Foods and Life Extension, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This latest report provides a deep insight into the global Potassium Iodide Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Potassium Iodide Tablet market, with both quantitative and qualitative data, to help readers understand how the Potassium Iodide Tablet market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
The study segments the Potassium Iodide Tablet market and forecasts the market size by Specification (＜ 60mg, 60 - 90mg and ＞ 90mg), by Application (Pregnant or Breastfeeding Women, Adult and Child,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
60 - 90mg
Segmentation by application
Pregnant or Breastfeeding Women
Segmentation by region
Middle East & Africa
Major companies covered
BTG Specialty Pharmaceuticals
KI Canada Ltd
Chapter 1: Scope of Potassium Iodide Tablet, Research Methodology, etc.
Chapter 2: Executive Summary, global Potassium Iodide Tablet market size (sales and revenue) and CAGR, Potassium Iodide Tablet market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Potassium Iodide Tablet sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Potassium Iodide Tablet sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Potassium Iodide Tablet market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Anbex, Inc, Recipharm, BTG Specialty Pharmaceuticals, NOW Foods, Life Extension, Pure Encapsulations, KI Canada Ltd, PCCA and Hexagon Nutrition and etc.
Chapter 14: Research Findings and Conclusion